←Back to Expert Scholars
Translational Medicine / 转化医学FGFR Inhibitor Therapy
Philippe Cassier
MD, PhD
🏢Centre Leon Berard🌐France
Medical Oncologist
55
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Philippe Cassier leads phase I and early drug development trials at Centre Leon Berard. He has contributed to FGFR inhibitor studies across multiple tumor types including sarcoma. His work includes first in human studies of novel small molecule inhibitors. He is an active contributor to European precision oncology research.
Share:
🧪Research Fields 研究领域
phase I trials
FGFR inhibitors
sarcoma
targeted therapy
drug development
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Philippe Cassier 的研究动态
Follow Philippe Cassier's research updates
留下邮箱，当我们发布与 Philippe Cassier（Centre Leon Berard）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment